To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to add a new set of measures to the 5-star rating system under the Medicare Advantage program in order to encourage increased access to biosimilar biological products.
The bill’s titles are written by its sponsor.
Sponsor and status
Sponsor. Representative for New York's 20th congressional district. Democrat.
Last Updated: Oct 8, 2019
Length: 4 pages
116th Congress (2019–2021)
This bill was introduced on October 8, 2019, in a previous session of Congress, but it did not receive a vote.
Although this bill was not enacted, its provisions could have become law by being included in another bill. It is common for legislative text to be introduced concurrently in multiple bills (called companion bills), re-introduced in subsequent sessions of Congress in new bills, or added to larger bills (sometimes called omnibus bills).
1 Cosponsor (1 Republican)
What legislators are saying
“Tonko Introduces Bipartisan Bill to Lower Prescription Drug Costs for American Consumers”
— Rep. Paul Tonko [D-NY20] (Sponsor) on Oct 15, 2019
Oct 8, 2019
Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.
Apr 26, 2021
Reintroduced Bill — Introduced
This activity took place on a related bill, H.R. 2855.
H.R. 4629 (116th) was a bill in the United States Congress.
A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
Bills numbers restart every two years. That means there are other bills with the number H.R. 4629. This is the one from the 116th Congress.
This bill was introduced in the 116th Congress, which met from Jan 3, 2019 to Jan 3, 2021. Legislation not passed by the end of a Congress is cleared from the books.
How to cite this information.
We recommend the following MLA-formatted citation when using the information you see here in academic work:
GovTrack.us. (2021). H.R. 4629 — 116th Congress: Star Rating for Biosimilars Act. Retrieved from https://www.govtrack.us/congress/bills/116/hr4629
“H.R. 4629 — 116th Congress: Star Rating for Biosimilars Act.” www.GovTrack.us. 2019. September 18, 2021 <https://www.govtrack.us/congress/bills/116/hr4629>
Star Rating for Biosimilars Act, H.R. 4629, 116th Cong. (2019).
|title=H.R. 4629 (116th)
|accessdate=September 18, 2021
|author=116th Congress (2019)
|date=October 8, 2019
|quote=Star Rating for Biosimilars Act
Where is this information from?
GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.